Published in Clin Pharm on February 01, 1987
Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemother (1989) 1.74
Inhibition of norfloxacin absorption by antacids. Antimicrob Agents Chemother (1990) 1.38
Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrob Agents Chemother (1993) 1.25
Effects of norfloxacin on hepatic genes expression of P450 isoforms (CYP1A and CYP3A), GST and P-glycoprotein (P-gp) in Swordtail fish (Xiphophorus Helleri). Ecotoxicology (2015) 0.75
Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. J Antimicrob Chemother (1987) 1.33
Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics. Am J Med (1987) 0.89
In vitro evaluation of nasogastric administration methods for phenytoin. Am J Hosp Pharm (1986) 0.80
Effect of formulary restriction of cefotaxime usage. Arch Intern Med (1985) 0.78
Furosemide-associated ototoxicity. Clin Pharm (1984) 0.75
No false "Hemoccult" reaction with ranitidine. N Engl J Med (1984) 0.75
Determination of clearance from a trough serum concentration at steady state. Drug Intell Clin Pharm (1987) 0.75
Lack of apparent effect of assay methodology on the pharmacokinetics of digoxin. Ther Drug Monit (1987) 0.75